MY ACCOUNT | NEWSLETTER |

Life expectancy tables for dogs, cats derived from clinical data


Human health metrics and life expectancy computations have been used for centuries. The first quantification of life expectancy was reported in England in the 19th century. Life expectancy tables have diverse uses for humans, which include monitoring the overall health status of populations over time, exploring health inequalities in socio-economic groups, and charting the progress of less developed nations. They are valuable for understanding the acute and long-term, direct and indirect effects of health conditions and medical interventions on survival.

Life expectancy data can be used to inform planning for healthcare provisions, economic policies, life insurance premiums and pension annuities.

Accurately calculating the life expectancy of dogs and cats would be of greatest interest in helping to understand the benefits of preventative care and the success of increasingly advanced medical interventions. 

There are few recent and methodologically robust life expectancy (LE) tables for dogs or cats. This study aimed to generate LE tables for these species with clinical records from more than 1,000 Banfield Pet hospitals in the U.S. 

Using Sullivan's method, LE tables were generated across survey years 2013-2019, by survey year, and for subpopulations defined by sex, adult body size group (purebred dogs only: toy, small, medium, large and giant), and median body condition score (BCS) over life. The deceased population for each survey year comprised animals with a recorded date of death in that year; survivors had no death date in that year and were confirmed living by a veterinary visit in a subsequent year. 

The dataset totaled 13,292,929 unique dogs and 2,390,078 unique cats. LE at birth was 12.69 years (95% CI: 12.68-12.70) for all dogs, 12.71 years (12.67-12.76) for mixed-breed dogs, 11.18 years (11.16-11.20) for cats, and 11.12 (11.09-11.14) for mixed-breed cats. 

LE at birth increased with decreasing dog size group and increasing survey year 2013 to 2018 for all dog size groups and cats. Female dogs and cats had significantly higher LE at birth than males: 12.76 years (12.75-12.77) vs. 12.63 years (12.62-12.64), and 11.68 years (11.65-11.71) vs. 10.72 years (10.68-10.75), respectively. 

Obese dogs (BCS 5/5) had a significantly lower LE at birth [11.71 years (11.66-11.77)] than overweight dogs (BCS 4/5) [13.14 years (13.12-13.16)] and dogs with ideal BCS 3/5 [13.18 years (13.16-13.19)]. The LE at birth of cats with BCS 4/5 [13.67 years (13.62-13.71)] was significantly higher than cats with BCS 5/5 [12.56 years (12.45-12.66)] or BCS 3/5 [12.18 years (12.14-12.21)]. 

Summary

The authors said that to their knowledge, this is the first study to generate life expectancy tables for dogs and cats in the U.S. and the first study to present these by median BCS. Some of the main findings were expected based on direct and indirect evidence in the literature, namely:

  • decreased life expectancy for the largest sizes of dogs compared to the smallest,
  • increased life expectancy of female versus male dogs and cats,
  • significantly lower life expectancy at all ages for underweight dogs and cats compared to those with an ideal, overweight or obese median BCS, and
  • a progressive increase in LE at birth for both species between 2013 and 2018.

Unexpected findings included the relatively constant life expectancy of underweight cats at all ages, and the higher life expectancy of overweight cats compared with cats that were ideal median BCS. Further study is needed to elucidate apparently complex, interrelated and dynamic relationships between median BCS and life expectancy.

In conclusion, these LE tables provide valuable information for veterinarians and pet owners and a foundation for research hypotheses, as well as being a stepping-stone to disease associated LE tables.

Mathieu Montoya, et al. “Life expectancy tables for dogs and cats derived from clinical data.” Front Vet Sci. 2023 Feb 21; 10:1082102. doi: 10.3389/fvets.2023.1082102.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top